Moreover, and specifically for glioma, this apparent paradox is tightly linked to another seemingly controversial observation of a condition—NSUN5 depletion via promoter hypermethylation—which favours tumour growth but at the same time is a good prognostic factor. Here, NSUN5 is linked to central nervous system cancer.